News

New FDA regulations effective September 2025 are reshaping how pharmaceutical companies advertise to consumers. The era of minimal risk disclosure is over. Marketers and procurement leaders now face heightened compliance expectations, intensified FDA enforcement, and stricter scrutiny of digital and social media campaigns.

Role expands leadership in this key region